Intranasal Therapeutic Peptide Vaccine Promotes Efficient Induction and Trafficking of Cytotoxic T Cell Response for the Clearance of HPV Vaginal Tumors.

Sierra, Gloria; Dorta-Estremera, Stephanie; Hegde, Venkatesh L; Nookala, Sita M K; Yanamandra, Ananta V; Sastry, K Jagannadha

Sierra, Gloria; Dorta-Estremera, Stephanie; Hegde, Venkatesh L; Nookala, Sita M K; Yanamandra, Ananta V; Sastry, K Jagannadha.

Afiliación

Sierra G; UTHealth Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Dorta-Estremera S; School of Medicine, University of Puerto Rico, San Juan, PR 00921, USA.
Hegde VL; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Nookala SMK; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Yanamandra AV; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sastry KJ; UTHealth Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Vaccines (Basel) ; 8(2)2020 May 29.

Article en En | MEDLINE | ID: mdl-32485935

Palabras clave

adjuvants; human papillomavirus; intranasal immunization; mucosal immunity; therapeutic vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google